Researchers discovered that two genetic variants, APOE4 and TREM2 R47H, increase Alzheimer’s disease risk by triggering inflammation in the brain’s immune cells, particularly in females. This research underscores the need for sex-specific treatments and reveals a potential new therapeutic target, the cGAS-STING pathway. Investigators at Weill Cornell Medicine have discovered that two genetic variants associated […]
Source link